As can be seen from the existing literature, SCARA5 is associated with conditions that include tumors, inflammation, CVD, hemophilia, retinopathy, bone lesions, connective-tissue disease, and pregnancy [10, 12, 25, 30–33]. This evidence concerns the gene SCARA5 and retinal disorder.